117,291 Shares in Astera Labs, Inc. (NASDAQ:ALAB) Purchased by AGF Management Ltd.

AGF Management Ltd. purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 117,291 shares of the company's stock, valued at approximately $15,535,000. AGF Management Ltd. owned about 0.07% of Astera Labs as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently bought and sold shares of the company. Steward Partners Investment Advisory LLC lifted its position in shares of Astera Labs by 99.0% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company's stock valued at $26,000 after buying an additional 99 shares during the last quarter. Kestra Investment Management LLC bought a new position in Astera Labs during the 4th quarter worth $28,000. Geneos Wealth Management Inc. bought a new position in Astera Labs during the 4th quarter worth $36,000. Global Retirement Partners LLC increased its stake in Astera Labs by 3,155.6% during the 4th quarter. Global Retirement Partners LLC now owns 293 shares of the company's stock worth $39,000 after acquiring an additional 284 shares during the period. Finally, ORG Wealth Partners LLC bought a new position in Astera Labs during the 4th quarter worth $42,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Stock Performance

Shares of ALAB opened at $66.05 on Wednesday. The stock has a 50 day moving average price of $101.65 and a two-hundred day moving average price of $88.10. The firm has a market capitalization of $10.71 billion and a P/E ratio of -38.18. Astera Labs, Inc. has a 52 week low of $36.22 and a 52 week high of $147.39.

Remove Ads

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Monday, February 10th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%. On average, equities analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Transactions at Astera Labs

In other news, CFO Michael Truett Tate sold 125,800 shares of Astera Labs stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $82.53, for a total value of $10,382,274.00. Following the transaction, the chief financial officer now owns 244,242 shares in the company, valued at approximately $20,157,292.26. The trade was a 34.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michael E. Hurlston sold 2,500 shares of Astera Labs stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $92.08, for a total value of $230,200.00. Following the completion of the transaction, the director now owns 91,794 shares in the company, valued at approximately $8,452,391.52. This represents a 2.65 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 570,990 shares of company stock valued at $50,242,702.

Analysts Set New Price Targets

ALAB has been the topic of a number of recent research reports. Needham & Company LLC restated a "buy" rating and set a $140.00 price objective on shares of Astera Labs in a research note on Tuesday, February 11th. Stifel Nicolaus lifted their price target on Astera Labs from $100.00 to $150.00 and gave the company a "buy" rating in a research note on Monday, January 6th. Craig Hallum lifted their price target on Astera Labs from $105.00 to $125.00 and gave the company a "buy" rating in a research note on Tuesday, February 11th. Barclays lifted their price target on Astera Labs from $87.00 to $135.00 and gave the company an "overweight" rating in a research note on Friday, January 17th. Finally, Northland Securities upgraded Astera Labs from a "market perform" rating to an "outperform" rating and set a $120.00 price target on the stock in a research note on Tuesday, January 28th. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Astera Labs currently has a consensus rating of "Buy" and a consensus target price of $115.33.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.